U. ACAR ÇEVİK Et Al. , "New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents," Archiv der Pharmazie , vol.356, no.5, 2023
ACAR ÇEVİK, U. Et Al. 2023. New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents. Archiv der Pharmazie , vol.356, no.5 .
ACAR ÇEVİK, U., ÇELİK, İ., PASHAYEVA, L., FATULLAYEV, H., BOSTANCI, H. E., ÖZKAY, Y., ... KAPLANCIKLI, Z. A.(2023). New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents. Archiv der Pharmazie , vol.356, no.5.
ACAR ÇEVİK, ULVİYE Et Al. "New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents," Archiv der Pharmazie , vol.356, no.5, 2023
ACAR ÇEVİK, ULVİYE A. Et Al. "New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents." Archiv der Pharmazie , vol.356, no.5, 2023
ACAR ÇEVİK, U. Et Al. (2023) . "New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents." Archiv der Pharmazie , vol.356, no.5.
@article{article, author={ULVİYE ACAR ÇEVİK Et Al. }, title={New benzimidazole-oxadiazole derivatives: Synthesis, α-glucosidase, α-amylase activity, and molecular modeling studies as potential antidiabetic agents}, journal={Archiv der Pharmazie}, year=2023}